Form 8-K - Current report:
SEC Accession No. 0001599298-25-000088
Filing Date
2025-05-01
Accepted
2025-05-01 16:10:10
Documents
43
Period of Report
2025-05-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K smmt-20250501.htm   iXBRL 8-K 32256
2 EX-99.1 a2025_prx0501xq12025earn.htm EX-99.1 34996
3 EX-99.2 q12025earningsdeck_final.htm EX-99.2 18647
7 a2025_prx0501xq12025earn001.jpg GRAPHIC 211491
8 a2025_prx0501xq12025earn002.jpg GRAPHIC 248739
9 a2025_prx0501xq12025earn003.jpg GRAPHIC 205260
10 a2025_prx0501xq12025earn004.jpg GRAPHIC 66518
11 a2025_prx0501xq12025earn005.jpg GRAPHIC 279360
12 a2025_prx0501xq12025earn006.jpg GRAPHIC 206782
13 a2025_prx0501xq12025earn007.jpg GRAPHIC 272378
14 a2025_prx0501xq12025earn008.jpg GRAPHIC 41132
15 a2025_prx0501xq12025earn009.jpg GRAPHIC 89254
16 a2025_prx0501xq12025earn010.jpg GRAPHIC 63883
17 a2025_prx0501xq12025earn011.jpg GRAPHIC 119288
18 a2025_prx0501xq12025earn012.jpg GRAPHIC 82113
19 a2025_prx0501xq12025earn013.jpg GRAPHIC 150095
20 a2025_prx0501xq12025earn014.jpg GRAPHIC 198684
21 a2025_prx0501xq12025earn015.jpg GRAPHIC 82963
22 q12025earningsdeck_final001.jpg GRAPHIC 44289
23 q12025earningsdeck_final002.jpg GRAPHIC 275251
24 q12025earningsdeck_final003.jpg GRAPHIC 148937
25 q12025earningsdeck_final004.jpg GRAPHIC 152524
26 q12025earningsdeck_final005.jpg GRAPHIC 118413
27 q12025earningsdeck_final006.jpg GRAPHIC 144663
28 q12025earningsdeck_final007.jpg GRAPHIC 124018
29 q12025earningsdeck_final008.jpg GRAPHIC 117830
30 q12025earningsdeck_final009.jpg GRAPHIC 58184
31 q12025earningsdeck_final010.jpg GRAPHIC 81957
32 q12025earningsdeck_final011.jpg GRAPHIC 111743
33 q12025earningsdeck_final012.jpg GRAPHIC 106097
34 q12025earningsdeck_final013.jpg GRAPHIC 44289
  Complete submission text file 0001599298-25-000088.txt   5530138

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20250501.xsd EX-101.SCH 1788
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20250501_lab.xml EX-101.LAB 21629
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20250501_pre.xml EX-101.PRE 12512
45 EXTRACTED XBRL INSTANCE DOCUMENT smmt-20250501_htm.xml XML 2735
Mailing Address 601 BRICKELL KEY DRIVE SUITE 1000 MIAMI FL 33131
Business Address 601 BRICKELL KEY DRIVE SUITE 1000 MIAMI FL 33131 305-203-2034
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

EIN.: 371979717 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36866 | Film No.: 25903170
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)